Breaking News

Financial Report: Hospira

Results were strong last quarter, driven by specialty injectables

The company saw growth last quarter, with much of that fueled by demand for specialty injectables.

2Q Revenues: $1,136 billion  +10.7%
2Q Earnings: $71 billion  +115%
YTD Revenue: $2,187 billion  +14.5%
YTD Earnings: $139 billion  +417.6%

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters